Does Mounjaro Cause Kidney Stones? A Doctor Explains

If you’ve started Mounjaro (tirzepatide) for weight loss or type 2 diabetes, you may have heard concerns about kidney stones. As an internal medicine physician, I frequently address questions about Mounjaro side effects, including whether this medication increases kidney stone risk. While Mounjaro is highly effective for metabolic health, its impact on kidney function—particularly kidney stones—is a valid concern. In this article, I’ll break down the evidence, explain why Mounjaro may contribute to kidney stones, and provide practical guidance for managing this potential side effect.

Why Does Mounjaro Cause Kidney Stones?

Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist that slows gastric emptying, reduces appetite, and improves insulin sensitivity. While these mechanisms are beneficial for weight loss and glycemic control, they can indirectly increase the risk of kidney stones. One of the primary reasons Mounjaro may contribute to kidney stones is dehydration. GLP-1 medications like Mounjaro often cause gastrointestinal side effects, such as nausea, vomiting, and diarrhea, which can lead to fluid loss. Dehydration concentrates urine, increasing the likelihood of crystal formation—particularly calcium oxalate or uric acid stones.

Additionally, Mounjaro’s effects on metabolism may alter urinary composition. Some studies suggest that rapid weight loss, which is common with Mounjaro, can elevate uric acid levels in the urine, a known risk factor for uric acid stones. Furthermore, changes in dietary habits—such as increased protein intake or reduced calcium consumption—can further predispose individuals to kidney stones while on Mounjaro. While not everyone on Mounjaro will develop kidney stones, these physiological changes explain why some patients are at higher risk.

How Common Is Kidney Stones on Mounjaro?

The exact prevalence of kidney stones in patients taking Mounjaro is not yet fully established, as large-scale, long-term studies are still ongoing. However, clinical trials and post-marketing reports provide some insights. In the SURMOUNT and SURPASS trials, kidney stones were not listed as a common Mounjaro side effect, but these studies were not specifically designed to track renal outcomes. Anecdotal reports from patients and clinicians suggest that kidney stones may occur in a small but notable subset of users.

A 2023 analysis of FDA adverse event reporting systems found that kidney stones were reported more frequently in patients taking GLP-1 agonists, including Mounjaro, compared to other diabetes or weight loss medications. However, it’s important to note that these reports do not prove causation. Factors such as pre-existing dehydration, a history of kidney stones, or metabolic conditions (e.g., gout) may contribute to the observed association. While kidney stones are not among the most common Mounjaro side effects, they are a potential risk worth monitoring, particularly in high-risk individuals.

How Long Does Mounjaro Kidney Stones Last?

The duration of kidney stones while taking Mounjaro depends on several factors, including stone size, composition, and individual hydration status. For most patients, kidney stones caused by Mounjaro (or other GLP-1 medications) are small (less than 5 mm) and may pass spontaneously within 1 to 2 weeks with proper hydration and pain management. However, larger stones (greater than 7 mm) may require medical intervention, such as lithotripsy or ureteroscopy, and could take longer to resolve.

If dehydration is the primary trigger, increasing fluid intake while continuing Mounjaro may help prevent new stones from forming. However, if kidney stones persist or recur despite hydration, your doctor may recommend adjusting your Mounjaro dosage or exploring alternative treatments. It’s also worth noting that kidney stone symptoms—such as flank pain, hematuria (blood in urine), or urinary urgency—may subside once the stone passes, but the underlying risk may remain if dehydration or metabolic factors are not addressed.

How to Manage Kidney Stones While Taking Mounjaro

If you develop kidney stones while on Mounjaro, proactive management can help alleviate symptoms and reduce the risk of recurrence. Here are evidence-based strategies:

1. Hydration: Aim for 2.5 to 3 liters of water daily to dilute urine and flush out crystals. This is the most critical step in preventing and managing kidney stones while on Mounjaro. If you experience nausea (a common Mounjaro side effect), sip fluids slowly or use electrolyte solutions to maintain hydration.

2. Dietary Adjustments: Reduce sodium intake (to <2,300 mg/day) and limit oxalate-rich foods (e.g., spinach, nuts, chocolate) if you’re prone to calcium oxalate stones. For uric acid stones, moderating purine-rich foods (e.g., red meat, shellfish) may help. A registered dietitian can provide personalized guidance.

3. Pain Management: Over-the-counter NSAIDs (e.g., ibuprofen) or acetaminophen can help manage pain while the stone passes. If pain is severe, your doctor may prescribe stronger analgesics or recommend medical intervention.

4. Monitor Urine Output: Track your urine output and color. Dark, concentrated urine suggests dehydration, while clear urine indicates adequate hydration. Consider using a urine dipstick to check for hematuria or pH imbalances.

5. Medication Review: If kidney stones persist, your doctor may evaluate whether Mounjaro is the primary culprit. In some cases, adjusting the dosage or switching to a different GLP-1 agonist (e.g., semaglutide) may be considered.

When to See Your Doctor About Mounjaro and Kidney Stones

While mild kidney stone symptoms can often be managed at home, certain red flags warrant immediate medical attention. Seek care if you experience:

• Severe, unrelenting flank or abdominal pain that does not improve with hydration or pain relievers.
• Fever, chills, or nausea/vomiting, which may indicate a urinary tract infection or obstruction.
• Inability to urinate or blood in the urine (hematuria), which could signal a blocked ureter.
• Recurrent kidney stones (2 or more episodes while on Mounjaro), as this may indicate an underlying metabolic issue.

Your doctor may order imaging (e.g., ultrasound or CT scan) to confirm the stone’s size and location. If the stone is large or causing complications, they may refer you to a urologist for further intervention. Additionally, if kidney stones are a recurring problem, your doctor may recommend discontinuing Mounjaro or exploring alternative weight loss or diabetes medications.

Mounjaro Kidney Stones vs Other GLP-1 Side Effects

Kidney stones are just one of many potential Mounjaro side effects, and their severity and management differ from other common issues. Here’s how kidney stones compare to other GLP-1-related side effects:

1. Gastrointestinal (GI) Symptoms: Nausea, vomiting, and diarrhea are the most common Mounjaro side effects, affecting up to 50% of users in clinical trials. These symptoms are usually transient, improving within 4 to 8 weeks of starting the medication. Unlike kidney stones, GI side effects are rarely severe enough to require discontinuation.

2. Hypoglycemia: While Mounjaro itself has a low risk of hypoglycemia, combining it with insulin or sulfonylureas can increase this risk. Hypoglycemia is typically acute and reversible with glucose intake, whereas kidney stones may require long-term management.

3. Pancreatitis: Rare but serious, pancreatitis has been reported with GLP-1 agonists, including Mounjaro. Symptoms include severe abdominal pain radiating to the back, nausea, and vomiting. Unlike kidney stones, pancreatitis requires immediate medical attention and discontinuation of the medication.

4. Gallbladder Disease: Mounjaro and other GLP-1 medications may increase the risk of gallstones due to rapid weight loss. Symptoms include right upper quadrant pain, nausea, and jaundice. While gallstones and kidney stones both cause pain, they affect different organ systems and require distinct treatments.

Compared to these side effects, kidney stones are less common but can be more persistent if underlying risk factors (e.g., dehydration, metabolic issues) are not addressed.

Does Mounjaro Dosage Affect Kidney Stones?

The relationship between Mounjaro dosage and kidney stone risk is not fully understood, but some evidence suggests that higher doses may increase the likelihood of dehydration and metabolic changes that predispose individuals to stones. Mounjaro is typically started at 2.5 mg weekly and titrated up to 15 mg weekly over several months. During dose escalation, GI side effects (e.g., nausea, vomiting) are more pronounced, which can lead to fluid loss and concentrated urine—key risk factors for kidney stones.

A 2023 study published in Diabetes Care found that patients on higher doses of GLP-1 agonists (e.g., 15 mg Mounjaro) were more likely to report dehydration-related adverse events, including kidney stones, compared to those on lower doses. However, the study did not establish a direct causal relationship, and individual susceptibility (e.g., history of kidney stones, baseline hydration status) likely plays a significant role.

If you develop kidney stones while on Mounjaro, your doctor may consider dose reduction or slower titration to minimize GI side effects and improve hydration. However, the decision to adjust dosage should balance the benefits of Mounjaro for weight loss or diabetes control against the risks of kidney stones.

Frequently Asked Questions

Does Mounjaro cause kidney stones in everyone?

No, Mounjaro does not cause kidney stones in everyone. While dehydration and metabolic changes from Mounjaro may increase the risk, most users do not develop stones. Individuals with a history of kidney stones, poor hydration habits, or metabolic disorders (e.g., gout) are at higher risk.

How long does kidney stones last on Mounjaro?

Most kidney stones caused by Mounjaro pass within 1 to 2 weeks with proper hydration and pain management. Larger stones or complications (e.g., obstruction) may require medical intervention and take longer to resolve. Recurrent stones may indicate an ongoing risk that needs addressing.

Can you prevent kidney stones on Mounjaro?

Yes, kidney stones on Mounjaro can often be prevented with adequate hydration (2.5–3 L/day), a balanced diet low in sodium and oxalates, and regular monitoring of urine output. If you’re prone to stones, your doctor may recommend additional measures, such as citrate supplements or urine pH testing.

Is kidney stones a reason to stop Mounjaro?

Not necessarily. If kidney stones are mild and manageable with hydration and dietary changes, you may continue Mounjaro under close monitoring. However, if stones are recurrent, severe, or causing complications, your doctor may recommend discontinuing Mounjaro or switching to an alternative medication.

Disclaimer from Dr. Amanda Liu: The information provided in this article is for educational purposes only and should not replace professional medical advice. If you are taking Mounjaro or experiencing kidney stone symptoms, consult your healthcare provider for personalized guidance. Individual responses to medications vary, and your doctor can help weigh the benefits and risks of continuing Mounjaro based on your unique health profile.